Resources

Publish Date
Letters
C4IP Letter to Senate Commerce, Science, & Transportation Committee on the Invent Here, Make Here Act of 2023

Dear Chairwoman Cantwell and Ranking Member Cruz, The Council for Innovation Promotion (C4IP) writes to express its concerns about the unintended consequences...

Public Comments
C4IP Comments RE: Inventorship Guidance for AI-Assisted Inventions (PTO-P-2023-0043)
Public Comments
C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (PTO-C-2024-0004)
Public Comments
C4IP Comments RE: Motion to Amend Practice and Procedures in Trial Proceedings Under the America Invents Act Before the Patent Trial and Appeal Board (PTO-P-2020-0060)
Public Comments
What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that would make...

Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that would make...

Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: First Edition

The U.S. economy is today not only the largest economy in the world – with an estimated GDP at over USD 25...

Public Comments
C4IP Comments RE: Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
Letters
C4IP Letter to Senate Judiciary IP Subcommittee on PERA

Dear Chairman Coons and Ranking Member Tillis, The Council for Innovation Promotion is a bipartisan coalition dedicated to promoting strong and effective...

Letters
Former Commerce Officials Letter to President Biden on March-in Rights

Dear President Biden, We write to express our concerns with the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights...

Public Comments
C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement
Resources:

Resources:

C4IP Letter to Senate Commerce, Science, & Transportation Committee on the Invent Here, Make Here Act of 2023,

05/15/2024

Resources:

Resources:

C4IP Comments RE: Inventorship Guidance for AI-Assisted Inventions (PTO-P-2023-0043),

05/13/2024

Resources:

Resources:

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (PTO-C-2024-0004),

05/13/2024

Resources:

Resources:

C4IP Comments RE: Motion to Amend Practice and Procedures in Trial Proceedings Under the America Invents Act Before the Patent Trial and Appeal Board (PTO-P-2020-0060),

05/03/2024

Resources:

Resources:

What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights,

04/09/2024

Resources:

Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

03/31/2024

Resources:

Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

03/30/2024

Resources:

Resources:

The Congressional Innovation Scorecard: First Edition,

03/21/2024

Resources:

Resources:

C4IP Comments RE: Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights,

02/06/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary IP Subcommittee on PERA,

02/06/2024

Resources:

Resources:

Former Commerce Officials Letter to President Biden on March-in Rights,

02/02/2024

Resources:

Resources:

C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement,

01/30/2024

Scroll to Top